Biogen Announces New Hope for Alzheimer’s Drug Candidate Aducanumab
On October 22, 2019, the biopharmaceutical company, Biogen, announced that they will be going to the FDA to seek approval
On October 22, 2019, the biopharmaceutical company, Biogen, announced that they will be going to the FDA to seek approval
The 2019 Research Rally Breakfast at the NDSC Annual Convention was attended by 400 families of loved ones with DS
In the next couple of months, LuMind IDSC will launch the LIFE-DSR (Longitudinal Investigation for Enhancing Down Syndrome Research) study.
[image_with_animation image_url=”6095″ image_size=”full” animation_type=”entrance” animation=”Fade In” hover_animation=”none” alignment=”” border_radius=”none” box_shadow=”none” image_loading=”default” max_width=”100%” max_width_mobile=”default”][/vc_row]The LuMind IDSC Foundation is excited to welcome
Giving back is not new to John’s Crazy Socks (JCS), who just announced they are donating $2 from every sale
We are very lucky at LuMind RDS that we have a way to help runners participate in ALMOST any race
BURLINGTON, Mass. [November 1], 2018 – With a combined $3M commitment from the Alana Foundation and biopharmaceutical companies H. Lundbeck
NEW YORK CITY—(September 5, 2018)—The inaugural Funding Futures New York Gala is set to take place on Thursday, September 20
PHOENIX – (August 14, 2018) – One of the largest retreats for mothers of children with Down syndrome – Rockin’ Mom
INDIANAPOLIS (July 31, 2018) – McCordsville, Indiana mother and Down syndrome advocate, Mari Kennedy, is helping accelerate breakthroughs in Down syndrome